Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings for MarketAxess Holdings

MarketAxess Holdings (NASDAQ:MKTX) has observed the following analyst ratings within the last quarter:

Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,400 Today

Copart (NASDAQ:CPRT) has outperformed the market over the past 5 years by 18.07% on an annualized basis producing an average annual return of 27.89%. Currently, Copart has a market capitalization of $25.67 billion.

Benzinga

What's Going On With Caribou Biosciences Shares Today?

Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are trading lower after the company reported additional data from its CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cowen & Co. Maintains Outperform Rating for Grocery Outlet Holding: Here's What You Need To Know

Cowen & Co. has decided to maintain its Outperform rating of Grocery Outlet Holding (NASDAQ:GO) and raise its price target from $42.00 to $45.00. Shares of Grocery Outlet Holding are trading up 2.38% over the last 24 hours, at $37.85 per share.

Benzinga

What 5 Analyst Ratings Have To Say About Cytokinetics

Within the last quarter, Cytokinetics (NASDAQ:CYTK) has observed the following analyst ratings:

Benzinga

Where Frontdoor Stands With Analysts

Frontdoor (NASDAQ:FTDR) has observed the following analyst ratings within the last quarter:

Benzinga

Peering Into Booking Holdings's Recent Short Interest

Booking Holdings's (NASDAQ:BKNG) short percent of float has fallen 5.29% since its last report. The company recently reported that it has 723.60 thousand shares sold short, which is 1.79% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Will Investors Notice Exciting Sign On United Therapeutics's Chart?

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Academy Sports's Ex-Dividend Date Is Wednesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from Academy Sports (NASDAQ:ASO).

Benzinga

ESSA Bancorp's Ex-Dividend Date Is Wednesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from ESSA Bancorp (NASDAQ:ESSA).

Benzinga

Why Shares Of Cogent Biosciences Are Trading Higher

Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Benzinga

2 Must-Own Tech Stocks in the Nasdaq-100

Investors’ worries about the Fed’s hawkish tilt to combat inflation have led several fundamentally sound tech stocks to plunge significantly in price this year. However, given the solid long-term prospects of the tech industry, we think it could be wise to invest in the shares of quality tech stocks in…

StockNews.com

Why BofA Believes It's A Good Time To Buy ProFrac

ProFrac Holding Corp. (NASDAQ: PFHC) is well-positioned to benefit from a material rise in fracking profitability through year end and into 2023.

Benzinga

Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump

U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Credit Suisse Cuts REV Group Price Target By 9%

Credit Suisse analyst Jamie Cook lowered the price target on REV Group Inc (NASDAQ:REVG) to $10 from $11 while maintaining the Underperform rating on the shares. The analyst stated that within the quarter, REVG did not experience supply chain improvement as expected, and in some instances, the situation worsened. REVG now expects supply chain challenges…

Benzinga

44 Stocks Moving In Friday's Mid-Day Session

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Benzinga

Why This Spirit Airlines Analyst Is Turning Bullish

A merger of Spirit Airlines Incorporated (NYSE: SAVE) is “a high probability outcome,” and a merger with JetBlue Airways Corporation (NASDAQ: JBLU) is more likely than with Frontier (NASDAQ: <

Benzinga

4 Analysts Have This to Say About Design Therapeutics

Within the last quarter, Design Therapeutics (NASDAQ:DSGN) has observed the following analyst ratings:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 11 Analyst Ratings Have To Say About Microchip Technology

Microchip Technology (NASDAQ:MCHP) has observed the following analyst ratings within the last quarter:

Benzinga

6 Analysts Have This to Say About Analog Devices

Analysts have provided the following ratings for Analog Devices (NASDAQ:ADI) within the last quarter:

Benzinga

Check Out What Whales Are Doing With BKNG

Someone with a lot of money to spend has taken a bearish stance on Booking Holdings (NASDAQ:BKNG). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Why RedBox Shares Are Skyrocketing Today

RedBox Entertainment Inc (NASDAQ: RDBX) shares are trading higher by 31.5% at $12.45 on above-average volume as the stock trends across social media platforms.

Benzinga

SciPlay's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, SciPlay (NASDAQ:SCPL) earned $32.00 million, a 162.3% increase from the preceding quarter. SciPlay also posted a total of $158.00 million in sales, a 2.33% increase since Q4.

Benzinga

Sight Sciences's Return On Capital Employed Overview

Benzinga Pro data, Sight Sciences (NASDAQ:SGHT) reported Q1 sales of $14.88 million. Earnings fell to a loss of $23.26 million, resulting in a 45.98% decrease from last quarter.

Benzinga

Elon Musk Recommends Investing In 'Physical Things' - Here Are 3 Physical Assets That Perform Well During High Inflation

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk posted in a thread on Twitter (NYSE: TWTR) in March, after inflation hit a 40-year high for the first time this year

1 … 407 408 409 410

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Micron Technology Inc

71 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.